Skip to main content
IQV
NYSE Industrial Applications And Services

IQVIA Reports Strong Q1 Results, Raises Full-Year EPS Guidance, and Repurchases $552M in Stock

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$152.5
Mkt Cap
$27.312B
52W Low
$134.645
52W High
$247.045
52W Position info
13% above low
Off High info
38% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

IQV is trading near its 52-week low of $134.645 (13% above the low).

Summary

IQVIA reported robust first-quarter results, including an 8.4% revenue increase and a 7.4% rise in Adjusted Diluted EPS, leading to an upward revision of its full-year Adjusted Diluted EPS guidance. The company also repurchased $552 million of its common stock.


Key Events · Earnings and Guidance · IQV

  • Strong First Quarter Financial Performance

    IQVIA reported first-quarter 2026 revenue of $4,151 million, an 8.4% increase year-over-year, and Adjusted Diluted Earnings per Share of $2.90, up 7.4% year-over-year. Free Cash Flow increased 15% year-over-year to $491 million.

  • Full-Year EPS Guidance Raised

    The company raised its full-year 2026 guidance for Adjusted Diluted Earnings per Share to a range of $12.65 to $12.95, while reaffirming revenue and Adjusted EBITDA guidance.

  • Significant Share Repurchase Program

    During the first quarter of 2026, IQVIA repurchased $552 million of its common stock, with $1,217 million of authorization remaining as of March 31, 2026.

  • Solid R&D Solutions Backlog and Bookings

    Research & Development Solutions reported a contracted backlog of $34.2 billion and net new bookings of $2.5 billion, resulting in a book-to-bill ratio of 1.04x for the quarter.


Analysis · IQV · Industrial Applications And Services

IQVIA Holdings Inc. delivered a strong first quarter, exceeding expectations with accelerated organic revenue growth and Adjusted Diluted EPS. The company's decision to raise its full-year Adjusted Diluted EPS guidance signals management's increased confidence in future profitability. Additionally, the substantial share repurchase program demonstrates a commitment to returning capital to shareholders and can be viewed as a positive signal regarding the company's valuation. Investors should monitor continued growth in R&D Solutions backlog and the execution of the share repurchase program.

At the time of this filing, IQV was trading at $152.50 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $27.3B. The 52-week trading range was $134.65 to $247.05. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

IQV - Latest Insights

IQV
Jul 31, 2026, 5:02 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $235.02
Real-time Price: $235.00 info
Change: -$0.020 (-0.01%) info
Market Cap: $38.684B info
IQV
Jul 28, 2026, 4:38 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $242.94
Real-time Price: $235.00 info
Change: -$7.94 (-3%) info
Market Cap: $38.684B info
IQV
Jul 28, 2026, 7:03 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $234.00
Real-time Price: $235.00 info
Change: +$1.00 (+0.43%) info
Market Cap: $38.684B info
IQV
Jul 28, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $234.00
Real-time Price: $235.00 info
Change: +$1.00 (+0.43%) info
Market Cap: $38.684B info
IQV
Jun 11, 2026, 4:46 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $181.06
Real-time Price: $235.00 info
Change: +$53.94 (+30%) info
Market Cap: $38.684B info